235 related articles for article (PubMed ID: 29637406)
1. Innovative Research Design to Meet the Challenges of Clinical Trials for Juvenile Dermatomyositis.
Rosina S; Varnier GC; Mazzoni M; Lanni S; Malattia C; Ravelli A
Curr Rheumatol Rep; 2018 Apr; 20(5):29. PubMed ID: 29637406
[TBL] [Abstract][Full Text] [Related]
2. Juvenile dermatomyositis: novel treatment approaches and outcomes.
Varnier GC; Pilkington CA; Wedderburn LR
Curr Opin Rheumatol; 2018 Nov; 30(6):650-654. PubMed ID: 30124602
[TBL] [Abstract][Full Text] [Related]
3. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
Giancane G; Lavarello C; Pistorio A; Oliveira SK; Zulian F; Cuttica R; Fischbach M; Magnusson B; Pastore S; Marini R; Martino S; Pagnier A; Soler C; Staņēvicha V; Ten Cate R; Uziel Y; Vojinovic J; Fueri E; Ravelli A; Martini A; Ruperto N;
Pediatr Rheumatol Online J; 2019 May; 17(1):24. PubMed ID: 31118099
[TBL] [Abstract][Full Text] [Related]
4. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A;
Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606
[TBL] [Abstract][Full Text] [Related]
5. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
Walling HW; Gerami P; Sontheimer RD
Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339
[TBL] [Abstract][Full Text] [Related]
6. Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.
Hinze CH; Speth F; Oommen PT; Haas JP
Pediatr Rheumatol Online J; 2018 Jun; 16(1):38. PubMed ID: 29925381
[TBL] [Abstract][Full Text] [Related]
7. Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance.
Sherman MA; Kim H; Banschbach K; Brown A; Gewanter HL; Lang B; Perron M; Robinson AB; Spitznagle J; Stingl C; Syverson G; Tory HO; Spencer CH; Tarvin SE
Pediatr Rheumatol Online J; 2023 Jan; 21(1):3. PubMed ID: 36609397
[TBL] [Abstract][Full Text] [Related]
8. Recent clinical trials in idiopathic inflammatory myopathies.
Leclair V; Lundberg IE
Curr Opin Rheumatol; 2017 Nov; 29(6):652-659. PubMed ID: 28763333
[TBL] [Abstract][Full Text] [Related]
9. [Juvenile dermatomyositis-what's new?].
Hinze C
Z Rheumatol; 2019 Sep; 78(7):627-635. PubMed ID: 31087132
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab.
Aggarwal R; Loganathan P; Koontz D; Qi Z; Reed AM; Oddis CV
Rheumatology (Oxford); 2017 Feb; 56(2):247-254. PubMed ID: 27837048
[TBL] [Abstract][Full Text] [Related]
11. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK; Lindsley CB; Pilkington CA; Punaro M; Ravelli A; Reed AM; Rouster-Stevens K; van Royen-Kerkhof A; Dressler F; Magalhaes CS; Constantin T; Davidson JE; Magnusson B; Russo R; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J; Ruperto N;
Arthritis Rheumatol; 2017 May; 69(5):911-923. PubMed ID: 28382778
[TBL] [Abstract][Full Text] [Related]
12. Update on the clinical management of juvenile dermatomyositis.
Huber AM
Expert Rev Clin Immunol; 2018 Dec; 14(12):1021-1028. PubMed ID: 30308133
[TBL] [Abstract][Full Text] [Related]
13. Clinical assessment in juvenile dermatomyositis.
Ravelli A; Ruperto N; Trail L; Felici E; Sala E; Martini A
Autoimmunity; 2006 May; 39(3):197-203. PubMed ID: 16769653
[TBL] [Abstract][Full Text] [Related]
14. Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.
Hinze CH; Oommen PT; Dressler F; Urban A; Weller-Heinemann F; Speth F; Lainka E; Brunner J; Fesq H; Foell D; Müller-Felber W; Neudorf U; Rietschel C; Schwarz T; Schara U; Haas JP
Pediatr Rheumatol Online J; 2018 Jun; 16(1):40. PubMed ID: 29940960
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the clinical characteristics and therapeutic effect of refractory juvenile dermatomyositis to tofacitinib].
Zhou QF; Luo Y; He TY; Ling JY; Xu YB; Yang J; Xia Y
Zhonghua Er Ke Za Zhi; 2023 Jun; 61(6):538-542. PubMed ID: 37312466
[No Abstract] [Full Text] [Related]
16. Therapeutic advances in myositis.
Aggarwal R; Oddis CV
Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
[TBL] [Abstract][Full Text] [Related]
17. Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index.
Rosina S; Consolaro A; Pistorio A; Rebollo-Giménez A; Bracaglia C; Dolezalova P; Guilaisne Bernard-Medina A; Herlin T; Trachana M; Vargová V; Wouters C; Carenini L; Ruperto N; Ravelli A;
RMD Open; 2024 Feb; 10(1):. PubMed ID: 38307698
[TBL] [Abstract][Full Text] [Related]
18. A Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases.
Sato JO; Sallum AM; Ferriani VP; Marini R; Sacchetti SB; Okuda EM; Carvalho JF; Pereira RM; Len CA; Terreri MT; Lotufo SA; Romanelli PR; Ramos VC; Hilario MO; Silva CA; Corrente JE; Saad-Magalhães C;
Clin Exp Rheumatol; 2009; 27(6):1031-8. PubMed ID: 20149327
[TBL] [Abstract][Full Text] [Related]
19. Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey.
Stringer E; Bohnsack J; Bowyer SL; Griffin TA; Huber AM; Lang B; Lindsley CB; Ota S; Pilkington C; Reed AM; Scuccimarri R; Feldman BM
J Rheumatol; 2010 Sep; 37(9):1953-61. PubMed ID: 20595275
[TBL] [Abstract][Full Text] [Related]
20. Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis.
Kim NN; Lio PA; Morgan GA; Jarvis JN; Pachman LM
Arch Dermatol; 2011 Jul; 147(7):831-5. PubMed ID: 21422326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
